 of dual
antiplatelet therapy.
Level of recommendation

2 (Weak)

Quality of evidence

B (Moderate)

In patients with a drug-eluting coronary stent requiring
open aneurysm repair, we recommend discontinuation
of P2Y12 platelet receptor inhibitor therapy 10 days

Journal of Vascular Surgery

Chaikof et al

5

Volume 67, Number 1

preoperatively with continuation of aspirin. The P